Selected references:
- Gershenson DM. Contemporary treatment of borderline ovarian tumors. Cancer Invest 1999;17:206–10
- Lin PS, Gershenson DM, Bevers MW, et at. The current status of surgical staging of ovarian serous borderline tumors. Cancer 1999;85:905–11
- Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31:539-57 Winter WE, Kucera PR, Rodgers W, et at. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 2002;110: 201–4
Further reading:
- Lin PS, Gershenson DM, Bevers MW, et at. The current status of surgical staging of ovarian serous borderline tumors. Cancer 1999;85:905–11
- Winter WE III, Kucera PR, Rodgers W, et at. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 2002;100:671–6
- Zanetta G, Rota S, Chiari S, et at. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001;19:2658–64
- Gershenson DM, Silva EG, Tortolero-Luma G, et at. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer 1998;83:2157–63
- Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31: 539–57
- Leake JF, Rader JS, Woodruff JD, et at. Retroperitoneal lymphatic involvement with epithelial ovarian tumors of low malignant potential. Gynecol Oncol 1991;42:124–30